Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 272

1.

Pitavastatin: an overview.

Saito Y.

Atheroscler Suppl. 2011 Nov;12(3):271-6. doi: 10.1016/S1567-5688(11)70886-8. Review.

PMID:
22152281
2.

Pitavastatin: novel effects on lipid parameters.

Chapman MJ.

Atheroscler Suppl. 2011 Nov;12(3):277-84. doi: 10.1016/S1567-5688(11)70887-X. Review.

PMID:
22152282
3.

Pitavastatin: clinical effects from the LIVES Study.

Teramoto T.

Atheroscler Suppl. 2011 Nov;12(3):285-8. doi: 10.1016/S1567-5688(11)70888-1. Review.

PMID:
22152283
4.

Are all statins the same? Focus on the efficacy and tolerability of pitavastatin.

da Silva PM.

Am J Cardiovasc Drugs. 2011;11(2):93-107. doi: 10.2165/11591190-000000000-00000. Review.

PMID:
21446776
5.
6.

Comparison of the efficacy and tolerability of pitavastatin and atorvastatin: an 8-week, multicenter, randomized, open-label, dose-titration study in Korean patients with hypercholesterolemia.

Lee SH, Chung N, Kwan J, Kim DI, Kim WH, Kim CJ, Kim HS, Park SH, Seo HS, Shin DG, Shin YW, Shim WJ, Ahn TH, Ho Yun K, Yoon MH, Cha KS, Choi SW, Han SW, Hyon MS.

Clin Ther. 2007 Nov;29(11):2365-73.

PMID:
18158077
7.

New evidence on pitavastatin: efficacy and safety in clinical studies.

Teramoto T, Shimano H, Yokote K, Urashima M.

Expert Opin Pharmacother. 2010 Apr;11(5):817-28. doi: 10.1517/14656561003641990. Review.

PMID:
20201733
8.

Comparative efficacy and safety of low-dose pitavastatin versus atorvastatin in patients with hypercholesterolemia.

Sansanayudh N, Wongwiwatthananukit S, Putwai P, Dhumma-Upakorn R.

Ann Pharmacother. 2010 Mar;44(3):415-23. doi: 10.1345/aph.1M522. Epub 2010 Feb 23.

PMID:
20179259
9.
10.

Pitavastatin - results from phase III & IV.

Betteridge J.

Atheroscler Suppl. 2010 Dec;11(3):8-14. doi: 10.1016/S1567-5688(10)71064-3. Review.

PMID:
21193153
11.

Pitavastatin in cardiometabolic disease: therapeutic profile.

Masana L.

Cardiovasc Diabetol. 2013;12 Suppl 1:S2. doi: 10.1186/1475-2840-12-S1-S2. Epub 2013 May 30. Review.

12.

Critical appraisal of the role of pitavastatin in treating dyslipidemias and achieving lipid goals.

Saito Y.

Vasc Health Risk Manag. 2009;5:921-36. Epub 2009 Nov 16. Review.

13.

[Pharmacological and pharmacokinetic features and clinical effects of pitavastatin (Livalo Tablet)].

Yamazaki H, Fujino H, Kanazawa M, Tamaki T, Sato F, Suzuki M, Kitahara M.

Nihon Yakurigaku Zasshi. 2004 May;123(5):349-62. Review. Japanese.

PMID:
15118259
14.

Pitavastatin: efficacy and safety in intensive lipid lowering.

Hayashi T, Yokote K, Saito Y, Iguchi A.

Expert Opin Pharmacother. 2007 Oct;8(14):2315-27. Review.

PMID:
17927486
15.

Pitavastatin - from clinical trials to clinical practice.

Masana L.

Atheroscler Suppl. 2010 Dec;11(3):15-22. doi: 10.1016/S1567-5688(10)71065-5. Review.

PMID:
21193154
16.

Multicenter collaborative randomized parallel group comparative study of pitavastatin and atorvastatin in Japanese hypercholesterolemic patients: collaborative study on hypercholesterolemia drug intervention and their benefits for atherosclerosis prevention (CHIBA study).

Yokote K, Bujo H, Hanaoka H, Shinomiya M, Mikami K, Miyashita Y, Nishikawa T, Kodama T, Tada N, Saito Y.

Atherosclerosis. 2008 Dec;201(2):345-52. doi: 10.1016/j.atherosclerosis.2008.02.008. Epub 2008 Feb 16.

PMID:
18472103
17.

Targeting low HDL-cholesterol to decrease residual cardiovascular risk in the managed care setting.

Cziraky MJ, Watson KE, Talbert RL.

J Manag Care Pharm. 2008 Oct;14(8 Suppl):S3-28; quiz S30-1. Review.

PMID:
19891279
18.

Pitavastatin and Atorvastatin double-blind randomized comPArative study among hiGh-risk patients, including thOse with Type 2 diabetes mellitus, in Taiwan (PAPAGO-T Study).

Liu PY, Lin LY, Lin HJ, Hsia CH, Hung YR, Yeh HI, Wu TC, Chen JY, Chien KL, Chen JW.

PLoS One. 2013 Oct 1;8(10):e76298. doi: 10.1371/journal.pone.0076298. eCollection 2013. Erratum in: PLoS One. 2014;9(11):e114175.

19.

The clinical impact of pitavastatin: comparative studies with other statins on LDL-C and HDL-C.

Teramoto T.

Expert Opin Pharmacother. 2012 Apr;13(6):859-65. doi: 10.1517/14656566.2012.660525. Epub 2012 Feb 15. Review.

PMID:
22332608
20.

Searching the place of pitavastatin in the current treatment of patients with dyslipidemia.

Barrios V, Escobar C, Zamorano JL.

Expert Rev Cardiovasc Ther. 2013 Dec;11(12):1597-612. doi: 10.1586/14779072.2013.844546. Review.

PMID:
24215190

Supplemental Content

Support Center